← back to search

Tsz-Lun Yeung

Ono Pharmaceutical (United States) · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer Cells and Metastasis, Cell Adhesion Molecules Research, Fibroblast Growth Factor Research, and TGF-β signaling in diseases.
h-index
20
citations
3,254
works
107
NIH funding
primary concept
Biology
email

Recent publications

Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
Cancer Cell 2021cited by 188position: middledoi
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
Nature Communications 2020cited by 69position: middledoi
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer
Clinical Cancer Research 2019cited by 73position: firstdoi
Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer
JNCI Journal of the National Cancer Institute 2018cited by 68position: firstdoi
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression
Cancers 2018cited by 49position: firstdoi
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
Journal of Clinical Investigation 2017cited by 131position: middledoi
Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth
Cell Metabolism 2016cited by 435position: middledoi
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment
Biomolecules 2016cited by 57position: firstdoi
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
American Journal of Physiology-Cell Physiology 2015cited by 382position: firstdoi
TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
Cancer Research 2013cited by 418position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Samuel C. Mok · Houston Methodist8 papers (2013–2020)Stephen T.C. Wong · Baylor College of Medicine6 papers (2015–2020)Cecilia S. Leung · University of Houston6 papers (2013–2019)Kay‐Pong Yip · University of South Florida4 papers (2015–2020)Jianting Sheng · Houston Methodist4 papers (2017–2020)Michael J. Birrer · University of Arkansas at Little Rock4 papers (2013–2019)Kwong‐Kwok Wong · The University of Texas at Austin3 papers (2013–2018)Karen H. Lu · The University of Texas MD Anderson Cancer Center3 papers (2018–2020) · 2 papers (2017–2018)Fuhai Li · Washington University in St. Louis2 papers (2016–2018)Melissa S. Thompson · University of Houston2 papers (2013–2018) · 1 papers (2018–2018) · 1 papers (2015–2015) · 1 papers (2020–2020)Chi-Lam Au-Yeung · University of Houston1 papers (2020–2020) · 1 papers (2018–2018) · 1 papers (2020–2020)Goli Samimi · University of Alabama at Birmingham1 papers (2013–2013) · 1 papers (2019–2019)Laura Bover · University of Houston1 papers (2019–2019)